Philip E. Thorpe

13.0k total citations · 1 hit paper
134 papers, 10.6k citations indexed

About

Philip E. Thorpe is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Philip E. Thorpe has authored 134 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 82 papers in Immunology and 38 papers in Biotechnology. Recurrent topics in Philip E. Thorpe's work include Toxin Mechanisms and Immunotoxins (47 papers), Angiogenesis and VEGF in Cancer (32 papers) and Transgenic Plants and Applications (32 papers). Philip E. Thorpe is often cited by papers focused on Toxin Mechanisms and Immunotoxins (47 papers), Angiogenesis and VEGF in Cancer (32 papers) and Transgenic Plants and Applications (32 papers). Philip E. Thorpe collaborates with scholars based in United States, United Kingdom and Germany. Philip E. Thorpe's co-authors include Sophia Ran, Rolf A. Brekken, Xianming Huang, Kazuhiko Tanzawa, Gerald McMahon, Douglas Hanahan, Shigeyoshi Itohara, Gabriele Bergers, Kazuhiko Tamaki and Takeshi Itoh and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Philip E. Thorpe

132 papers receiving 10.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

2000 2.2k citations Rolf A. Brekken, Philip E. Thorpe et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Philip E. Thorpe	5.8k	3.5k	2.6k	2.4k	1.5k	134	10.6k
Raffaella Giavazzi	6.2k 1.1×	1.4k 0.4×	4.0k 1.6×	3.4k 1.4×	736 0.5×	232	11.4k
Øystein Fodstad	8.1k 1.4×	2.6k 0.8×	5.6k 2.2×	4.5k 1.8×	1.0k 0.7×	307	14.8k
Ralph A. Reisfeld	8.0k 1.4×	5.6k 1.6×	5.2k 2.0×	2.3k 0.9×	917 0.6×	219	16.7k
Piero Musiani	5.8k 1.0×	5.0k 1.5×	4.1k 1.6×	3.9k 1.6×	550 0.4×	212	12.2k
Corazon D. Bucana	8.2k 1.4×	2.0k 0.6×	4.6k 1.8×	3.6k 1.5×	636 0.4×	145	13.9k
Avraham Raz	9.4k 1.6×	7.6k 2.2×	3.9k 1.5×	1.8k 0.7×	612 0.4×	228	15.2k
Gert Riethmüller	3.1k 0.5×	3.3k 1.0×	5.1k 2.0×	2.2k 0.9×	331 0.2×	112	10.4k
Reiji Kannagi	11.1k 1.9×	4.5k 1.3×	1.9k 0.7×	1.0k 0.4×	720 0.5×	303	15.0k
Elda Tagliabue	6.8k 1.2×	2.5k 0.7×	5.4k 2.1×	3.3k 1.4×	409 0.3×	259	13.0k
Arne Östman	9.8k 1.7×	2.9k 0.8×	4.6k 1.8×	2.9k 1.2×	400 0.3×	165	16.8k

Countries citing papers authored by Philip E. Thorpe

Since Specialization

Citations

This map shows the geographic impact of Philip E. Thorpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Thorpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Thorpe more than expected).

Fields of papers citing papers by Philip E. Thorpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Thorpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Thorpe. The network helps show where Philip E. Thorpe may publish in the future.

Co-authorship network of co-authors of Philip E. Thorpe

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Thorpe. A scholar is included among the top collaborators of Philip E. Thorpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Thorpe. Philip E. Thorpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wojtukiewicz, Marek Z., et al.. (2016). Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco. Advances in Clinical and Experimental Medicine. 25(3). 505–511. 12 indexed citations

Yin, Yi, Xianming Huang, Kristi D. Lynn, & Philip E. Thorpe. (2013). Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. Cancer Immunology Research. 1(4). 256–268. 128 indexed citations

Huang, Xianming, Dan Ye, & Philip E. Thorpe. (2011). Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine. Vaccine. 29(29-30). 4785–4793. 33 indexed citations

Liang, Yayun, et al.. (2010). Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors. Breast Cancer Research and Treatment. 125(2). 407–420. 23 indexed citations

Vasalatiy, Olga, Piyu Zhao, Mark Woods, et al.. (2010). Strategies for labeling proteins with PARACEST agents. Bioorganic & Medicinal Chemistry. 19(3). 1106–1114. 4 indexed citations

Yin, Yi, et al.. (2009). Abstract #5463: Fully human anti-phosphatidylserine antibody inhibits the growth of prostate cancer in mice. Cancer Research. 69. 5463–5463. 1 indexed citations

Thorpe, Philip E., et al.. (2008). Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(10). 2217–2224. 47 indexed citations

Thorpe, Philip E., et al.. (2007). ANTIBODY-MEDIATED TARGETING OF “INSIDE-OUT” ANIONIC PHOSPHOLIPIDS IN VIRAL DISEASE (47.21). The Journal of Immunology. 178(1_Supplement). S70–S70. 1 indexed citations

Mohamedali, Khalid A., Ann T. Poblenz, Charles R. Sikes, et al.. (2006). Inhibition of Prostate Tumor Growth and Bone Remodeling by the Vascular Targeting Agent VEGF121/rGel. Cancer Research. 66(22). 10919–10928. 25 indexed citations

10.

Mohamedali, Khalid A., Daniel Kedar, Paul Sweeney, et al.. (2005). The Vascular-Targeting Fusion Toxin VEGF121/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors. Neoplasia. 7(10). 912–920. 30 indexed citations

11.

Beck, Adam W., Troy A. Luster, Andrew F. Miller, et al.. (2005). Combination of a monoclonal anti‐phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. International Journal of Cancer. 118(10). 2639–2643. 65 indexed citations

12.

He, Jin & Philip E. Thorpe. (2004). Anti-tumor effects of duramycin-IgG conjugate. Cancer Research. 64. 1053–1053. 3 indexed citations

13.

Li, Shuzhen, et al.. (1996). Heparin-steroid conjugates lacking glucocorticoid or mineralocorticoid activities inhibit the proliferation of vascular endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1310(1). 86–96. 10 indexed citations

14.

Gheţie, Victor, et al.. (1991). The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. Journal of Immunological Methods. 142(2). 223–230. 44 indexed citations

15.

Engert, Andreas, Alex Brown, & Philip E. Thorpe. (1991). Resistance of myeloid leukaemia cell lines to ricin a-chain immunotoxins. Leukemia Research. 15(11). 1079–1086. 18 indexed citations

16.

Ghetie, Maria-Ana, Richard May, Mark Till, et al.. (1989). The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cellular Immunology. 118(1). 85–99. 32 indexed citations

17.

Wawrzynczak, Edward J., Alex F. Drake, & Philip E. Thorpe. (1988). Circular dichroism of isolated ricin A- and B-chains. Biophysical Chemistry. 31(3). 301–305. 10 indexed citations

18.

Blakey, David C. & Philip E. Thorpe. (1986). Effect of Chemical Deglycosylation on the in vivo Fate of Ricin A-Chain. PubMed. 3(3). 189–196. 33 indexed citations

19.

Vitetta, Ellen S. & Philip E. Thorpe. (1985). Immunotoxins Containing Ricin A Or B Chains with Modified Carbohydrate Residues Act Synergistically in Killing Neoplastic B Cells In Vitro *. PubMed. 2(3). 191–198. 16 indexed citations

20.

Thorpe, Philip E., W. C. J. Ross, Alan J. Cumber, et al.. (1981). Cytotoxicity Acquired by Conjugation of an Anti‐Thy_1.1 Monoclonal Antibody and the Ribosome‐Inactivating Protein, Gelonin. European Journal of Biochemistry. 116(3). 447–454. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact